Beta‐Adrenergic Blockers as a Potential Treatment for COVID‐19 Patients
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Beta‐Adrenergic Blockers as a Potential Treatment for COVID‐19 Patients
Authors
Keywords
-
Journal
BIOESSAYS
Volume 42, Issue 11, Pages 2000094
Publisher
Wiley
Online
2020-08-28
DOI
10.1002/bies.202000094
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- (2020) Haibo Zhang et al. INTENSIVE CARE MEDICINE
- Connecting With Patients—The Missing Links
- (2020) Lisa Sanders et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
- (2020) Canrong Wu et al. Acta Pharmaceutica Sinica B
- Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19
- (2020) Huilan Zhang et al. ANNALS OF INTERNAL MEDICINE
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Pulmonary Embolism in COVID-19 Patients: Awareness of an Increased Prevalence
- (2020) Julien Poissy et al. CIRCULATION
- SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?
- (2020) Gabriela M Kuster et al. EUROPEAN HEART JOURNAL
- ECMO for ARDS due to COVID-19
- (2020) Silvio A. Ñamendys-Silva HEART & LUNG
- The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design
- (2020) Spyridon G. Deftereos et al. Hellenic Journal of Cardiology
- SARS-CoV-2: a storm is raging
- (2020) Savannah F. Pedersen et al. JOURNAL OF CLINICAL INVESTIGATION
- Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?
- (2020) Murray Esler et al. JOURNAL OF HYPERTENSION
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
- (2020) Muthiah Vaduganathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acute Pulmonary Embolism Associated with COVID-19 Pneumonia Detected by Pulmonary CT Angiography
- (2020) Franck Grillet et al. RADIOLOGY
- COVID-19, ECMO, and lymphopenia: a word of caution
- (2020) Brandon Michael Henry Lancet Respiratory Medicine
- Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
- (2020) Lei Fang et al. Lancet Respiratory Medicine
- Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
- (2020) Yadi Zhou et al. Cell Discovery
- Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019
- (2020) Zhe Zhu et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): Pooled analysis of early reports
- (2020) Brandon Michael Henry et al. JOURNAL OF CRITICAL CARE
- Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients
- (2020) Chaofu Wang et al. EBioMedicine
- Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC
- (2019) Kam-Leung Siu et al. FASEB JOURNAL
- Safety and efficacy of beta-blockers to improve oxygenation in patients on veno-venous ECMO
- (2019) Jeroen J.H. Bunge et al. JOURNAL OF CRITICAL CARE
- Surfactant Protein D Dampens Lung Injury by Suppressing NLRP3 Inflammasome Activation and NF-κB Signaling in Acute Pancreatitis
- (2018) Jia Yu et al. SHOCK
- Repositioning of the β-Blocker Carvedilol as a Novel Autophagy Inducer That Inhibits the NLRP3 Inflammasome
- (2018) Wei-Ting Wong et al. Frontiers in Immunology
- Epigenetic silencing of ZNF132 mediated by methylation-sensitive Sp1 binding promotes cancer progression in esophageal squamous cell carcinoma
- (2018) Dong Jiang et al. Cell Death & Disease
- Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
- (2017) Andrew Rhodes et al. INTENSIVE CARE MEDICINE
- Potentially Inadvertent Immunomodulation: Norepinephrine Use in Sepsis
- (2016) Roeland F. Stolk et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Acute respiratory distress syndrome
- (2016) Rob Mac Sweeney et al. LANCET
- Inhalation of a Short-Acting β2-Adrenoreceptor Agonist Induces a Hypercoagulable State in Healthy Subjects
- (2016) Mais Ali-Saleh et al. PLoS One
- NOREPINEPHRINE
- (2015) Claude Martin et al. SHOCK
- β2-Adrenoceptor Involved in Smoking-Induced Airway Mucus Hypersecretion through β-Arrestin-Dependent Signaling
- (2014) Yujiao Zhou et al. PLoS One
- Propranolol induces apoptosis of human umbilical vein endothelial cells through downregulation of CD147
- (2013) W. Xie et al. BRITISH JOURNAL OF DERMATOLOGY
- β-Adrenergic receptors stimulate interleukin-6 production through Epac-dependent activation of PKCδ/p38 MAPK signalling in neonatal mouse cardiac fibroblasts
- (2011) Chao Chen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effects of an Inhaled β2-Agonist on Cardiovascular Function and Sympathetic Activity in Healthy Subjects
- (2011) Eric M Snyder et al. PHARMACOTHERAPY
- ACE2–angiotensin-(1–7)–Mas axis and oxidative stress in cardiovascular disease
- (2010) Luiza A Rabelo et al. HYPERTENSION RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More